Bill > HB1296

This bill establishes a three-year pilot program, called the Breakthrough Treatments for Georgia Heroes Suicide Prevention Pilot Program, starting January 1, 2027, to support clinical research and provide access to certain "eligible breakthrough treatments" for veterans and retired first responders suffering from conditions like post-traumatic stress disorder, treatment-resistant depression, major depressive disorder, and traumatic brain injury. "Eligible breakthrough treatments" include specific devices or drugs that have received "breakthrough device designation" or "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA), as well as ibogaine-based therapies and transcranial magnetic stimulation, or other similar treatments deemed appropriate by the department. The program, which will be administered by the department and can partner with research institutions, will use funds to establish research sites, conduct clinical trials and studies to evaluate treatment effectiveness and cost, subsidize treatment costs, invest in clinical infrastructure, provide workforce education, and disseminate treatment guidelines. The program is set to terminate on January 1, 2030, and the bill will only become effective if funds are specifically appropriated by the General Assembly. The department is required to submit an annual report detailing the program's implementation and effectiveness.

Health and Social Services, Military Affairs and Security

https://www.legis.ga.gov/legislation/73173